Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q1FY26 scheduled to be held on July 24, 2025 at 03:30 P.M. (IST)
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that it will hold an earnings conference call for the first quarter of FY26 (quarter ended June 30, 2025). The call is scheduled for Thursday, July 24, 2025, at 3:30 PM IST and will be moderated by Ambit Capital. Key company representatives participating include Managing Director Swapnil Shah, Chairperson Sanjay Majmudar, and CFO Deval Shah. The call follows the upcoming release of the company's unaudited standalone and consolidated financial results for Q1FY26. An audio recording and transcript will be made available on the company's website afterwards.
This is a routine procedural announcement with no direct impact on the stock price. Investors should watch the Q1FY26 results and the management commentary on the call for insights into the company's financial performance and outlook.